Earlier this May, Attana participated at the conference Advances In Cell-Based Screening In Drug Discovery 2022
The fourth edition of the conference was held at Astra Zeneca’s R&D site in Gothenburg on May 10–12. Attana participated along with leading scientists from academia, industry and the vendor community to discuss the latest advancements and best practices in cell assay profiling and their application for target identification, target validation and compound optimisation purposes.Attana participated in the discussions and presented how Attana’s Cell-based QCM Interaction studies are applied in Drug Discovery. Attana’s QCM technology received broad interest from participants, and it was clear